Validation of AI for Personalized Assessment and Rehabilitation of Upper Limb in Children With Unilateral Cerebral Palsy

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age5-15
SponsorIRCCS Fondazione Stella Maris

About this trial

Unilateral Cerebral palsy (UCP) is the most common neurological chronic disease in childhood with a significant burden on children, their families and health care system.

AInCP aims to develop evidence-based clinical Decision Support Tools (DST) for personalized functional diagnosis, Upper Limb (UpL) assessment and home-based intervention for children with UCP, by developing, testing and validating trustworthy Artificial Intelligence (AI) and cost-effective strategies. The AInCP approach will: i) establish a clinical diagnosis and accurate prognosis for treatment response of individual UCP profiles, by employing a multimodal approach including clinical phenotyping, advanced brain imaging and real-life monitoring of UpL function, and ii) provide personalized home-based treatment, from advanced ICT and AI technologies.

The AInCP will build upon personalized diagnostic and rehabilitative DST (dDST and rDST) to be developed and validated through large observational and rehabilitation studies, including at least 200 and 150 children with UCP, respectively. Using data driven and AI approach, dDST and rDST will be combined for developing a theranostic DST (tDST) that will allow the re-designing of an economical, ethical, sustainable decision-making process for delivering a personalized and validated approach, focused on the care, monitoring and rehabilitation of UpL in children with UCP. AInCP is a significant example of a transdisciplinary approach, where all project collaborators (clinicians, data scientists, physicists, engineers, economists, ethicists, SMEs, children and parent associations) will work closely together in building the AInCP approach. This approach will, therefore, hinge on transdisciplinary contributions, multi- dimensional data, sets of innovative devices and fair AI-based algorithms, clinically effective and able to reduce users? and market barriers of acceptability, reimbursability and adoption of the proposed solution.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Children with confirmed diagnosis of UCP mainly spastic form

Ages from 5 to 15 years old

Manual ability levels from I to III in the Manual Ability Classification System (MACS)

Disqualifiers

Severe Upper Limb (UpL) impairment (MACS ≥ level IV: inability to grasp)

Botulinum toxin-A injections in UpL within 6 months prior to study entry

UpL surgery within 12 months prior to study entry

Severe comobordities and/or severe cognitive disability

Trial population

Children aged from 5 to 15 years old with a diagnosis of Unilateral Cerebral Palsy, mainly spastic form, with an impairment at the Upper Limb from mild to severe. Children aged from 5 to 15 years old with a typical development.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

  • Artificial Intelligence for combining multi-domain data acquisition

    Other intervention

    Artificial Intelligence and machine learning techniques to combine data coming from multidomains data collection (such as clinical multiaxial assessments and questionnaires, Neuroimaging, Upper limb movement analysis during clinical assessment and daily life )

Treatment groups

500 Participants
are divided into 2 treatment groups
Group A: Typically developing children1 intervention
Group B: Children with Unilateral Cerebral Palsy1 intervention

Trial outcomes

Primary outcomes

1

score of modified Ashworth Scale (MAS)

Test for estimating the muscle tone (i.e., the resistance felt by the examiner when performing a passive stretch of a muscle), which will be apply to the muscles of the upper limb. The child will lie or sit in a comfortable position, and the examiner will stretch the upper limb in different ways, in order to assess the tension each muscle imposes when stretched.

Time frame
Months 1-24
2

score of grip strenght by means of Jamar dynamometer Grip strength will be assessed with the Jamar dynamometer

Jamar is a regular hydraulic dynamometer and is the most widely reported device used to measure grip strength. The child will perform three trials for each hand, where he/she will be asked to squeeze the handle of the dynamometer as strongly as possible. The values shown on the monitor will be noted for each trial.

Time frame
Months 1-24
3

score of mirror movements

Mirror movements of the hands refer to the involuntary movements of the less-affected hand, which mimic voluntary movements of the more affected hand. These movements will be assessed with the Woods and Teuber scale (Woods \& Teuber, 1978), which is a five-point scale describing the degree of mirror movements. The child will be asked to perform three tasks shown in figure 2: (1) fist opening and clenching, (2) finger opposition (thumb sequentially touches other four digits), and (3) finger tapping (fingers are sequentially lifted from the table surface) and after observation of the examiner, the mirror movements will be classified.

Time frame
Months 1-24
4

score of Stereognosis (tactile object identification)

The ability to identify objects only by touching them will be assessed with a simple test that includes 12 daily objects (e.g., a spoon, a toothbrush, a coin). The child will be asked to touch some items one-by-one, with his/her vision occluded and will have to report the name of the item touched in every trial.

Time frame
Months 1-24

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

IRCCS Fondazione Stella Maris

Lead sponsor

University of Pisa

Collaborator

University of Castilla-La Mancha

Collaborator

Fight The Stroke

Collaborator

SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA

Collaborator

Noldus Information Technology Bv

Collaborator

Khymeia

Collaborator

Tyromotion GMBH

Collaborator

The University of Queensland

Collaborator

University of Salento

Collaborator

This trial is not recruiting at the moment. You can still explore other options: